ConductScience.org, home

Trial · NCT02610868

Results by group122

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 1Serious TEAEs7participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 2Serious TEAEs14participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 3Serious TEAEs3participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 4Serious TEAEs2participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 1Severe TEAEs5participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 2Severe TEAEs8participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 3Severe TEAEs2participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 4Severe TEAEs2participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 1TEAEs Related to Study Medication42participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 2TEAEs Related to Study Medication26participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 3TEAEs Related to Study Medication4participants
Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE)Treatment Session 4TEAEs Related to Study Medication2participants
Occurrence of Adverse Events of Special Interest (AESI)Treatment Session 1Aspiration0participants
Occurrence of Adverse Events of Special Interest (AESI)Treatment Session 2Aspiration1participants
Occurrence of Adverse Events of Special Interest (AESI)Treatment Session 3Aspiration0participants
Occurrence of Adverse Events of Special Interest (AESI)Treatment Session 4Aspiration0participants
Occurrence of Adverse Events of Special Interest (AESI)Treatment Session 1Aspirational pneumonia0participants
Occurrence of Adverse Events of Special Interest (AESI)Treatment Session 2Aspirational pneumonia1participants
Occurrence of Adverse Events of Special Interest (AESI)Treatment Session 3Aspirational pneumonia0participants
Occurrence of Adverse Events of Special Interest (AESI)Treatment Session 4Aspirational pneumonia0participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02610868/results